关于最小化COVID-19对个人、社区和卫生保健系统影响的指南摘要——美国,2022年8月
随着SARS-CoV-2持续全球传播,高水平的疫苗和感染诱导免疫以及有效治疗和预防工具的可用性已大幅降低医学显著COVID-19疾病风险。CDC建议采取战略方法,依赖疫苗接种和治疗预防严重疾病,在可行处使用多组分预防措施,并特别强调保护重症高风险人群。当前优先事项包括确保人们了解风险、通过疫苗/治疗/非药物干预保护自己和他人、暴露后检测和戴口罩、有症状时检测、感染后隔离至少5天。
要点
- CDC推荐依赖疫苗接种和治疗预防严重疾病,在可行处使用多组分预防措施,并特别强调保护重症高风险人群。
- 个人医学显著COVID-19风险取决于暴露风险和感染后发展为严重疾病的风险。
- 暴露风险可通过非药物干预(改善通风、室内戴口罩或呼吸器、检测)减轻。
核心结论
- CDC recommends a strategic approach to minimizing the impact of COVID-19 on health and society that relies on vaccination and therapeutics to prevent severe illness; use of multicomponent prevention measures where feasible; and particular emphasis on protecting persons at high risk for severe illness.
研究设计与样本
- 本指南由CDC制定,基于当前科学、生物医学和公共卫生工具的可用性以及背景变化(如人群免疫水平和当前流行变异株)提出公共卫生建议。
主要发现
- 高水平的疫苗和感染诱导免疫以及有效治疗和预防工具的可用性已大幅降低医学显著COVID-19疾病(严重急性疾病和COVID-19后状况)及相关的住院和死亡风险。
- 个人医学显著COVID-19风险取决于暴露于SARS-CoV-2的风险和感染后发展为严重疾病的风险。
- 暴露风险可通过非药物干预减轻,包括改善通风、室内使用口罩或呼吸器以及检测。
- 医学显著疾病风险随年龄、残疾状态和基础疾病增加,但通过疫苗接种、既往感染或两者获得的免疫以及及时获取有效的生物医学预防措施和治疗而大幅降低。
关键数值与推荐
- CDC建议采取战略方法最小化COVID-19对健康和社会的影响,依赖疫苗接种和治疗预防严重疾病;在可行处使用多组分预防措施;并特别强调保护重症高风险人群。
- 应加强扩大疫苗接种和治疗的可及性,包括对免疫缺陷者使用暴露前预防、抗病毒药物和治疗性单克隆抗体,以降低医学显著疾病和死亡风险。
- 保护重症高风险人群的努力必须确保所有人获得信息以了解个人风险,并高效公平地获得疫苗接种、治疗、检测和其他预防措施。
- 当前预防医学显著疾病的优先事项应聚焦于确保人们:1)了解自身风险;2)通过疫苗、治疗和必要时非药物干预采取措施保护自己和他人;3)如果暴露则接受检测并戴口罩;4)如果有症状则接受检测,如果感染则隔离至少5天。
临床怎么用
- 临床实践中应遵循CDC建议,依赖疫苗接种和治疗预防严重疾病,在可行处使用多组分预防措施,并特别强调保护重症高风险人群。
- 应加强扩大疫苗接种和治疗的可及性,包括对免疫缺陷者使用暴露前预防、抗病毒药物和治疗性单克隆抗体。
- 应确保所有人获得信息以了解个人风险,并高效公平地获得疫苗接种、治疗、检测和其他预防措施。
- 应确保人们了解自身风险、通过疫苗/治疗/非药物干预保护自己和他人、暴露后检测和戴口罩、有症状检测、感染后隔离至少5天。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As SARS-CoV-2, the virus that causes COVID-19, continues to circulate globally, high levels of vaccine- and infection-induced immunity and the availability of effective treatments and prevention tools have substantially reduced the risk for medically significant COVID-19 illness (severe acute illness and post-COVID-19 conditions) and associated hospitalization and death (1). These circumstances now allow public health efforts to minimize the individual and societal health impacts of COVID-19 by focusing on sustainable measures to further reduce medically significant illness as well as to minimize strain on the health care system, while reducing barriers to social, educational, and economic activity (2). Individual risk for medically significant COVID-19 depends on a person's risk for exposure to SARS-CoV-2 and their risk for developing severe illness if infected (3). Exposure risk can be mitigated through nonpharmaceutical interventions, including improving ventilation, use of masks or respirators indoors, and testing (4). The risk for medically significant illness increases with age, disability status, and underlying medical conditions but is considerably reduced by immunity derived from vaccination, previous infection, or both, as well as timely access to effective biomedical prevention measures and treatments (3,5). CDC's public health recommendations change in response to evolving science, the availability of biomedical and public health tools, and changes in context, such as levels of immunity in the population and currently circulating variants. CDC recommends a strategic approach to minimizing the impact of COVID-19 on health and society that relies on vaccination and therapeutics to prevent severe illness; use of multicomponent prevention measures where feasible; and particular emphasis on protecting persons at high risk for severe illness. Efforts to expand access to vaccination and therapeutics, including the use of preexposure prophylaxis for persons who are immunocompromised, antiviral agents, and therapeutic monoclonal antibodies, should be intensified to reduce the risk for medically significant illness and death. Efforts to protect persons at high risk for severe illness must ensure that all persons have access to information to understand their individual risk, as well as efficient and equitable access to vaccination, therapeutics, testing, and other prevention measures. Current priorities for preventing medically significant illness should focus on ensuring that persons 1) understand their risk, 2) take steps to protect themselves and others through vaccines, therapeutics, and nonpharmaceutical interventions when needed, 3) receive testing and wear masks if they have been exposed, and 4) receive testing if they are symptomatic, and isolate for ≥5 days if they are infected.
引用
- Massetti GM, Jackson BR, Brooks JT, et al. Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems - United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35980866. doi:10.15585/mmwr.mm7133e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。